BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SNCA
,
T cell receptor signaling pathway
,
Obesity
,
Embryo
,
Avian flu virus
,
Clofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
hdac inhibitor
Summary
General Info
Curated Studies
Most Correlated Studies
Effect of HDAC inhibitors on expression of androgen induced genes
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Lymphoblastoid TK6 cells treated with various histone deacetylase (HDAC) inhibitors
HepG2 liver cells treated for 24hr with the HDAC inhibitor Trichostatin A
Explore Curated Studies Results
Literature
Most Relevant Literature
Histone deacetylase (HDACs) inhibitors: Clinical applications.
An updated patent review of histone deacetylase (HDAC) inhibitors in cancer (2020 - present).
Underlying anti-cancer mechanisms of histone deacetylase (HDAC) inhibitors in tamoxifen-resistant br…
Development of peptoid-based heteroaryl-decorated histone deacetylase (HDAC) inhibitors with dual-st…
NO-HDAC dual inhibitors.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma
HDAC Inhibitor Augmentation to Clozapine
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Safety and Effect of The HDAC Inhibitor Panobinostat on HIV-1 Expression in Patients on Suppressive …
Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination With Bortezomib in Patients With Rel…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ